RPN1 is involved in N-glycosylation and was found (among other genes) to be downregulated upon treatment of androgen-independent PCa xenografts with 17β oestradiol that led to inhibition of tumour growth [47]. The gene discussed is RPN1; the disease is posterior cortical atrophy.